ストックスクリーナーアプリを入手
33.76
6.26%
1.99
アフターアワーズ：
33.40
-0.36
-1.07%
前日終値:
$31.77
開ける：
$32.06
24時間の取引高:
1.66M
Relative Volume:
0.98
時価総額：
$4.17B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-7.9623
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+10.91%
1か月 パフォーマンス:
-5.65%
6か月 パフォーマンス:
+18.83%
1年 パフォーマンス:
+33.02%
1日の値動き範囲:
$31.72
$33.82
1週間の範囲:
$29.91
$33.82
52週間の値動き範囲:
$15.81
$38.53
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
33.76 | 4.17B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Piper Sandler maintains Overweight on Guardant Health stock By Investing.com - Investing.com UK
GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Guardant Health, Inc. (NASDAQ:GH) Sees Large Decline in Short Interest - MarketBeat
Why Guardant Health, Inc. (NASDAQ:GH) Could Be Worth Watching - Simply Wall St
Natera: Poised For A Great Future But I'd Wait For A Pullback (NASDAQ:NTRA) - Seeking Alpha
Sheffield United takeover completed by COH Sports - Reuters
FDA approves blood-based test screens for colon cancer - MSN
Geode Capital Management LLC Purchases 29,686 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock - Investing.com India
Guardant Health Partners with MiBA to Transform Cancer Care with AI-Powered Precision Oncology - StockTitan
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Franklin Resources Inc. - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock By Investing.com - Investing.com South Africa
Meaningful Insights Biotech Analytics and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care - Marketscreener.com
Guardant Health and COTA partner in advanced oncology R&D - TipRanks
Guardant Health Partners with COTA to Revolutionize Cancer Drug Development Through AI-Powered Data - StockTitan
Y Intercept Hong Kong Ltd Sells 38,937 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health teams up with Boehringer for cancer test By Investing.com - Investing.com Australia
Guardant Health teams up with Boehringer for cancer test - Investing.com
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer - Business Wire
Guardant Health Partners with Boehringer Ingelheim on Breakthrough Lung Cancer Diagnostic Test - StockTitan
Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 2,320 Shares of Stock - MarketBeat
Guardant Health director Tariq Musa sells $81,200 in stock - Investing.com
681,074 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Lord Abbett & CO. LLC - MarketBeat
XTX Topco Ltd Has $409,000 Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives $40.60 Consensus Target Price from Analysts - MarketBeat
(GH) Trading Report - Stock Traders Daily
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Eastern Progress Online
Verition Fund Management LLC Buys 25,900 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium - The Bakersfield Californian
Wellington Management Group LLP Purchases 6,618,785 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Showcase Breakthrough Liquid Biopsy Research at Major Breast Cancer Symposium - StockTitan
Pier Capital LLC Buys 42,575 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Bought by Two Sigma Advisers LP - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Temasek Holdings Private Ltd Reduces Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Charles Schwab Investment Management Inc. Has $23.01 Million Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week - Yahoo Finance
Strong week for Guardant Health (NASDAQ:GH) shareholders doesn't alleviate pain of three-year loss - Simply Wall St
Guardant Health stock soars to 52-week high of $37.04 By Investing.com - Investing.com Nigeria
Guardant Health Inc (GH) Shares Up 4.11% on Dec 4 - GuruFocus.com
Guardant Health stock soars to 52-week high of $37.04 - Investing.com
Guardant Health Stock Flashing Surefire ‘Buy’ Signal - Forbes
The Manufacturers Life Insurance Company Sells 28,746 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health (FRA:5GH) Shares Outstanding (EOP) : 123.2 Mil (As of Sep. 2024) - GuruFocus.com
Liquid Biopsy Market Is Booming So Rapidly with Major Giants - openPR
Guardant awarded nearly $293M in false ad trial against Natera - MedTech Dive
Erste Asset Management GmbH Buys New Stake in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Fred Alger Management LLC Sells 43,039 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
GH (Guardant Health) EBITDA per Share : $-3.86 (TTM As of Sep. 2024) - GuruFocus.com
Guardant Health (STU:5GH) EPS (Diluted) : €-3.89 (TTM As of Sep. 2024) - GuruFocus.com
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
Guardant Health Inc (GH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kalia Kumud | Chief Information Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
2,690 |
0 |
21,098 |
| Freeman Chris | Chief Commercial Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,595 |
0 |
35,852 |
| EAGLE CRAIG | Chief Medical Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,381 |
0 |
27,343 |
| Chudova Darya | Chief Technology Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,006 |
0 |
57,786 |
| Bell Michael Brian | Chief Financial Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
2,084 |
0 |
27,772 |
| Talasaz AmirAli | Co-Chief Executive Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
11,462 |
0 |
2,215,894 |
| Talasaz AmirAli | Co-Chief Executive Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
94,555 |
0 |
2,304,640 |
| Eltoukhy Helmy | Co-Chief Executive Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
11,462 |
0 |
2,315,728 |
| Eltoukhy Helmy | Co-Chief Executive Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
94,555 |
0 |
2,404,474 |
| Krognes Steve E. | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
155 |
0 |
10,220 |
0.42%
大文字化:
|
ボリューム (24 時間):